ICAD 241115 2.50P (ICAD241115P2500) Stock Options, News & Quotes

0.80
+0.45+128.57%

15min DelayClose Nov 15 16:00 ET

0.80High0.80Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Jaguar8

Apr 11 07:08

$iCAD Inc (ICAD.US)$
NEWS
iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
iCAD, Inc. announces partnership with Densitas and showcases ProFound Cloud at SBI symposium, highlighting advancements in breast cancer detection technology
NASHUA, N.H., April 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will sh...

Jaguar8

Apr 8 15:42

$iCAD Inc (ICAD.US)$
NEWS
iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting

Moomoo AI

Mar 2 08:12

iCAD's subdued revenue growth projections and P/S ratio in line with industry peers could risk shareholders' investments and potential investors might pay an unnecessary premium. The current P/S ratio and share price may not be sustainable if revenue growth doesn't improve.

There's Reason For Concern Over ICAD, Inc.'s (NASDAQ:ICAD) Massive 39% Price Jump

Moomoo AI

Jan 30 07:09

Mr. Doyle's appointment to the iCAD Board is viewed positively due to his vast experience in healthcare and technology. His role is anticipated to be crucial as iCAD advances its innovative AI-powered solutions to enhance global patient outcomes.

Press Release: ICAD Expands Board of Directors With Appointment of Michael J. Doyle, FACHE as New Board Member

Moomoo AI

Oct 23, 2023 07:08

iCAD's CEO sees the acquisition as an accelerator for Xoft's access and growth, believing Elekta's leadership will positively impact patients and healthcare.

Press Release: ICAD, Inc. Announces Sale of Xoft, Its Brachytherapy Business Line, to Elekta